Partner, Health & Life sciences, Technopolis Group
Joined March 2013
- Tweets152
- Following98
- Followers106
- Likes89
Data from clinical trials is essential to know if a medicine is safe and effective to treat a health condition. However, conducting clinical trials is a complex task. François Houÿez @eurordis presents sobering statistics about trial recruitment challenges at #DIAEurope2025.
What can #scientometrics and #data mining of research outputs can tell us about #ageing research in the UK? @Cris_rosemberg presents at @HealthyAgeingUK conference “Adding Life to Years”. @TechnopolisGrp – at London, England
Visualising biological processes is truly a magical part of science! I had the privilege to be part of this exciting global landscaping study for Wellcome. @TechnopolisGrp @wellcometrust
AgeingFit Event 2023 in Lille was a great opportunity to discuss a positive future for ageing! In the panel discussion, on the back of many healthy ageing studies at Technopolis Group, I argued that ageing policies require a complex adaptive systems appro…lnkd.in/gnnwcHza
It is inspiring to attend #healthyageing2022 and kick off the evaluation of UKRI Healthy Ageing Challenge. @HealthyAgeingUK @TechnopolisGrp – at London, England
ALT UK Research and Innovation challenge director, George McGinnis opens the 2022 Healthy Ageing Conference
1
The UK's Efficacy and Mechanism Evaluation programme addresses a crucial #funding gap in the #health #research landscape. If you are curious to know what it achieved over the past 10 years, read our recent peer-reviewed #impact report: doi.org/10.3310/eme08200
This Post is from an account that no longer exists. Learn more
1
How did the UK research funding agency work, adapt and respond to the #COVID19 pandemic? The answer is in our recently published report! @UKRI_news @TechnopolisGrp
This Post is from an account that no longer exists. Learn more
1
Peter Varnai retweeted
Curious how experimentation can improve science funding – not just in theory but also in practice? 🎲🧪
Check out our new @RoRInstitute @IGLglobal @EMBO @snsf_ch report for an overview full of real world examples:
rori.figshare.com/articles/r…
Why strengthening health systems is vital across the world ukri.org/blog/why-strengthen…
We are proud to have supported UKRI & Wellcome by reviewing the Health Systems Research Initiative that funds high quality and impactful research on issues most relevant to communities in LMICs. Read the report and impact stories: orlo.uk/8sIMs @UKRI_News @wellcometrust
This Post is from an account that no longer exists. Learn more
My colleague @Thyra_deJongh discusses important issues on the needs and priorities for innovation for #RareDiseases at the @CeBIL_Center annual symposium. @cambridgelaw @TechnopolisGrp
2
Why not use "fire drill" type of stress testing to build stronger #research & #innovation #system? We know future global risks, we can use scenarios, we should develop new #policy. #COVID19 gave us a shock, are we ready to learn? @TechnopolisGrp @EUScienceInnov
Academics could participate in military-style war games to prepare for future emergencies such as catastrophic pollution, extreme heat or financial meltdowns, under plans being considered by the @EU_Commission, writes @DavidMJourno
bit.ly/2VWu4TO
1
This was my first experiment with #foresight for EU policy makers. It led to 5 scenarios that made me reflect on the #COVID19 pandemic and its possible #impact. The report is now published: doi.org/10.2777/293413 @EUScienceInnov @TechnopolisGrp @AITtomorrow2day @FraunhoferISI
This Post is from an account that no longer exists. Learn more
2
It is still a long road to diagnosis and an exhausting search for information that might not be out there. Let's keep on working on making the impact of rarity as manageable as possible - key message from @RSkarberg @rare2030 @eurordis
"The knowledge travels not the patient" says @SKyriakidesEU as a key principle at the @rare2030 #foresight in #RareDiseases policy conference. @eurordis @EU_Health
Pleased to see my colleague's @Thyra_deJongh contribution to the important dialogue on the role of #intellectualproperty in pharmaceutical #innovation and #accesstomedecine this evening. Great discussion @YNatsis @EPHA_EU @TechnopolisGrp #A2MDialogues
epha.org/the-eu-ip-strategy-…
1
1
Technopolis UK Health team is expanding! If you are passionate about health policy, research and innovation, and want to make a difference, then apply to work with us: lnkd.in/dEabvvS
#consulting #health #policy #applynow @TechnopolisGrp
This has been a good collaboration between @TechnopolisGrp and Radu Gheorghiu & Bianca Dragomir of Institutul de Prospectiva, Matthias Weber @AITtomorrow2day, Kerstin Cuhls @FraunhoferISI and Sabine Oertelt-Prigione @smoertelt @radboudumc - many thanks to all!
This Post is from an account that no longer exists. Learn more
1